← feed

Is NCT03445013 results overdue?

Yes — results are overdue. Primary completion was 2018-01-31; the FDAAA-801 reporting deadline (2019-01-31) passed 2698 days ago and no results are posted on ClinicalTrials.gov.

A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis

NCT IDNCT03445013 ↗
SponsorNovan, Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-01-31 (ACTUAL)
Reporting deadline2019-01-31 (completion + 365d)
Days overdue2698
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 8f6f427b1990e55b… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03445013. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →